- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Allergy
Volume 2014 (2014), Article ID 654632, 7 pages
The Effectiveness of Acupuncture Compared to Loratadine in Patients Allergic to House Dust Mites
1Clinic of Otorhinolaryngology, Department of Medicine, University Hospital Dresden, Fetscherstraße 74, 01307 Dresden, Germany
2Institute for Medical Informatics and Biometry, Department of Medicine, University Hospital Dresden, Fetscherstraße 74, 01307 Dresden, Germany
Received 23 March 2014; Revised 6 May 2014; Accepted 6 May 2014; Published 5 June 2014
Academic Editor: Ralph Mösges
Copyright © 2014 Bettina Hauswald et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background. The aim of this work was to evaluate the clinical effectiveness of acupuncture and its impact on the immune system in comparison to loratadine in the treatment of persistent allergic rhinitis caused by house dust mites. Methods. In this study, 24 patients suffering from persistent allergic rhinitis induced by house dust mites were treated either with acupuncture () or with loratadine (). The evaluation of the data was based on the subjective and the objective rhinoconjunctivitis symptom scores, specific and total IgE, and interleukins (IL-4, IL-10, and IFN-γ) as markers for the activity of Th1 or Th2 cells. Results. The treatments with acupuncture as well as with loratadine were considered effective in the patients’ subjective assessment, whereby the effect of the acupuncture tended to be assessed as more persistent after the end of treatment. A change in the specific or the total IgE was not detectable in either group. The interleukin profile showed the tendency of an increasing IL-10 value in the acupuncture group. The results of the study show that the effectiveness of acupuncture is comparable to that of loratadine. Conclusion. Acupuncture is a clinically effective form of therapy in the treatment of patients suffering from persistent allergic rhinitis. The results indicate the probability of an immunomodulatory effect.
With a prevalence of 20 to 30%, allergic rhinitis is one of the most frequent atopic diseases in Western Europe [1–3]. It leads to a decrease of the patients’ quality of life  and causes great cost for medication and social benefits .
House dust mites, namely, Dermatophagoides pteronyssinus and D. farinae, are two of the most common persistent allergens. In 30% of all house dust mite allergies, a development of allergic bronchial asthma with coexisting nasal symptoms is expected. Especially in patients suffering from untreated allergic rhinitis, an exacerbation usually follows 5–15 years after the first occurrence of nasal symptoms .
Traditional Chinese medicine (TCM), of which acupuncture is a part, gains in importance as an addition to conventional therapies. According to a report of the World Health Organization of 2002  and to clinical studies , acupuncture is ranked among the sufficient methods for the treatment of allergic rhinitis and further allergic diseases such as bronchial asthma [9, 10]. Despite the conventional forms of therapy, 64% of patients suffering from persistent allergic rhinitis (PER) desire acupuncture as an alternative form of therapy . Two of the latest multicentre and randomised trials found evidence for a significant improvement of symptoms and the quality of life through acupuncture in patients with allergic rhinitis [1, 12].
Acupuncture, which is described as immunomodulatory therapy [13, 14], has already been examined for its effect and tested for cellular  and humoral  components of the immune system. In the last decade, numerous findings concerning the key role of CD4+ cells were made. Depending on the subtype, very different cytokines are produced. These can be regarded as prospective markers for the effectiveness of the therapy. Th1 cells mainly express the cytokine interleukin-2 (IL-2) and interferon- (IFN-)γ, which cause a cellular immune response, while Th2 cells release interleukins (IL) 4, 5, 10, and 13, which control the maturation of B lymphocytes to cells producing antibodies and their total IgE [16–19].
Examinations show that IL-10 can be considered as markers in the course of the therapy . In several studies on bronchial asthma [10, 21, 22] and allergic rhinitis [23–25], it was possible to show in animal testing as well as in patients that the cytokine profile of IL-10 can be modulated through acupuncture. At the same time, an improvement of the symptoms could be observed. Only fragmentary data are available on the effect of acupuncture on interleukins 4 (IL-4) and 5 (IL-5) and INF-γ which are involved in the Th1/Th2 equilibrium [10, 24].
It was the objective of this investigation to prove the effectiveness of acupuncture in the treatment of PER by comparing it with the effectiveness of antihistaminic loratadine as well as to gain a better understanding of the mechanisms of action of acupuncture through the examination of the interleukin profile.
2. Material and Methods
Patients in the outpatient department for allergy of the ENT clinic in Dresden suffering from PER were included in this study if a house dust mite allergy was ascertained by means of specific symptoms, skin prick test, and the assessment of the allergen specific IgE. With regard to the skin prick test (Allergopharma Joachim Ganzer KG, Reinbek), a sensitisation to Dermatophagoides pteronyssinus or D. farinae was then given if the diameter of the wheal measured ≥3 mm after 20 minutes . The CAP-FEIA system of Pharmacia & Upjohn Diagnostics AB, Uppsala, Sweden, was used for the allergological in vitro diagnostics for the determination of the total and the specific IgE. A total IgE of more than 100 kU/L as well as a specific IgE of more than 0.70 kU/L (CAP class 2) [5, 26, 27] was used to verify a sensitisation.
The cytokine profile was examined through the interleukins 4 (IL-4) and 10 (IL-10) and IFN-γ using the ELISA technique by Quantikine Immunoassay, Firma R&D Systems, Wiesbaden-Nordenstadt, Germany.
Exclusion criteria were pregnancy, continuous immunotherapy, other therapies influencing the immune system like glucocorticoids or chemotherapeutics, or the use of additional antiallergic medication.
2.1. Study Design
This study included 30 patients. The data of 24 patients could be collected fully until the end of the study and were evaluated accordingly (acupuncture group: and loratadine group: ). The average age of the patients was years. The mean duration of the disease was years. Table 1 shows the mean age of both treatment groups.
2.2. Therapy Groups
The patients were randomly assigned to the different treatment groups. Patients being treated with acupuncture received twelve acupuncture sessions in total, two sessions a week, using the same acupuncture points for every patient. Sterile, disposable needles made of stainless steel (Seirin, Dreieich/Germany) were used for body (0.3 × 0.3 mm in strength) and for face and ear acupuncture (0.2 × 0.15 mm in strength).
To allow for standardisation and comparability, all patients were acupunctured at the same points which were chosen in accordance with the rules of TCM. Needles were inserted unilaterally or bilaterally at the following points: LI 20, Ex-HN 12, Ex-HN 3, BL 1, BL 2, LI 4, LI 11, ear pont 78, and ear point 55 (Figures 1, 2, and 3). In addition, all patients werde acupuntured at LU 20, GB 20, SI 3, and ST 36 (not shown).
The needles were kept in place for 20 minutes. All patients were treated by the same physician throughout the whole study in order to allow for a standardisation.
Patients treated with loratadine took 10 mg of loratadine (Lisino, Essex Pharma GmbH) in the morning of each day over the treatment period of 21 days.
2.3. Course of the Study
The patients were examined three times during this study. The first examination took place before the treatment (), the second at the day after the end of treatment (), and the third after an interval of 10 weeks without therapy ().
At all three points, the clinical examination included anterior rhinoscopy, an estimation of the current nasal symptoms by use of the symptom score, and a blood sample (one tube for heparinised whole blood and one for serum each time).
2.4. Symptom Scores
All symptom scores were recorded on a 5-point scale (FPS).
2.4.1. Objective Symptom Scores
For the anterior rhinoscopy, the condition of the mucosa and the size of the nasal concha were recorded by the physician. Mucosal reddening and swelling of the inferior nasal concha were rated in the following score: 0 = normal, 1 = slightly changed, 2 = moderately changed, 3 = severely changed, and 4 = most severely changed.
2.4.2. Subjective Symptom Scores
While the objective nasal symptoms and findings were recorded three times in the course of the study, subjective symptoms (complaints) were determined retrospectively in the form of patient interviews. Nasal obstruction and secretion were evaluated using the following scale: 0 = free of symptoms, 1 = slight but noticeable symptoms, not interfering with daily activities, 2 = moderate symptoms, hardly interfering with daily activities and sleep, 3 = severe symptoms, clearly interfering with daily activities and sleep, and 4 = most severe symptoms, substantially interfering with daily activities and sleep.
The assessment of sneezing attacks was classified into 3 categories: 0 = no sneezing attacks, 1 = rare sneezing attacks, 1-2 sneezing attacks per day, and 2 = frequent sneezing attacks with more than 3 attacks per day.
2.4.3. Total Symptom Score
All symptom scores were summed up to a total symptom score in order to elucidate the therapeutic effect.
2.5. Subjective Estimation of the Therapeutic Effect
At examinations and , the subjective state of health was evaluated by comparing the afflictions prior to the therapy with the current ones (1 = improved and 2 = unchanged or worsened).
The data collected were evaluated using the statistical software SPSS Version 21 for Microsoft Windows. The results were given in form of mean ± standard deviation or standard error of the mean. The study was planned as repeated measures design and consequently evaluated by means of an analysis of variance. A significance level of was considered statistically significant.
In the acupuncture group, 87% of the patients reported an improvement of their afflictions at the end of therapy (). 13% did not notice a change at all at and still not at , 10 weeks after the end of therapy. At , 20% did not notice a change in comparison to the beginning of therapy () anymore. In the loratadine group, 67% of the patients stated an improvement at , while 33% did not detect an improvement. At none of the patients treated with loratadine noticed an improvement in comparison to (see Figure 4).
3.1. Total Sum Score
Looking at the subjective and objective symptoms separately, there is no significant difference noticeable, neither in the course of the therapy nor between the groups. The total sum score, however, showed significant changes in the time course of the therapy. Both in the acupuncture and the loratadine group, a significant improvement was gained under therapy. In the ten-week period following the therapy, a significant deterioration which led to the recurrence of the allergic symptoms was shown in the loratadine group, while the significant improvement of the symptoms persisted in the acupuncture group (multivariate tests ). Comparing both groups, no significance was ascertainable (see Figure 5).
3.2. Allergic Parameter (Total IgE; Specific IgE Dermatophagoides pteronyssinus/D. farinae)
Neither the acupuncture nor the loratadine group showed a significant difference in the specific IgE or the total IgE.
3.3. Interleukin Profile (IL-4 and IFN-γ)
The intermediate IL-4 level in the acupuncture group slightly increased during therapy, between and , from 0.182 pg/mL to 0.185 pg/mL. It then decreased to 0.177 pg/mL during the period without treatment, between and . Contrarily, in the loratadine group, the IL-4 level already decreased during therapy from 0.13 pg/mL () to 0.112 () and increased then to 0.126 pg/mL s ().
In the acupuncture group, the serum level of IFN-γ increased between and from 4.799 pg/mL to 5.844 pg/mL and decreased between and to 4.399 pg/mL. The intermediate IFN-γ level of the loratadine group showed a similar course. After the increase from 5.186 pg/mL to 5.664 pg/mL at the beginning of therapy, the IFN-γ serum level decreased to 5.504 pg/mL ().
None of the observed differences of the IL-4 and IFN-γ were significant.
3.4. Interleukin Profile IL-10
For the IL-10 serum level, an increase from 1.001 pg/mL () to 1.49 pg/mL () was observed in the acupuncture group. Also, after the end of therapy, an increase to 1.857 pg/mL () was shown. In the loratadine group, the IL-10 also increased from 1.84 pg/mL () to 2.013 pg/mL () but decreased after the end of treatment to 1.909 pg/mL ().
Even though the increase of the IL-10 serum level was not significant, it showed a distinct tendency to increase in the partial eta squared values (Figure 6).
In order to prove that acupuncture can serve as complementary form of therapy in the treatment of PER, its effectiveness was compared to that of loratadine. It was also examined whether acupuncture has a long-term effect beyond the end of the treatment period. Furthermore, the theory according to which the therapy effect of acupuncture is based on an immunomodulatory effect was checked.
The role of IL-10 in the pathogenesis of allergic diseases during treatment and its level changes in the serum are currently the subject of controversial discussion . It was shown that the IL-10 is able to obstruct the histamine release of activated mast cells . In addition, an increased IL-10 level in the nasal mucosa led to a definite reduction of nasal allergy symptoms of patients with dust mite allergy after nasal provocation . Thus, the IL-10 level could function as a marker for the effectiveness of antiallergic therapy. Some reasearchers suggest that the interleukin levels, especially that of IL-10, change under acupuncture [10, 21, 24].
In our study, we were likewise able to observe that the IL-10 level tends to increase in the acupuncture group. This observation could be an indication for the immunomodulatory effect of acupuncture. Due to the small number of patients, however, it was not possible to show a significance.
Even though there is information that the level of the other cytokines investigated here, namely, IL-4 and IFN-γ, can change during acupuncture [10, 21, 24], this was not observed in our study, which might be due to the small sample size.
In a number of studies, the effectiveness of acupuncture in regard to quality of life and the reduction of medication as well as significant improvements of the clinical symptoms has already been shown [1, 8, 12, 30, 31]. Even though our results did not show any significant differences of the single symptoms, a significant improvement of the symptoms was observed in the total sum scores in both the acupuncture and loratadine groups during the course of the treatment. This outcome correlates with the patients’ subjective assessment of their state of health recorded immediately at the end of treatment. The difference between both groups develops within the 10-week period without treatment, between and . While the patients in the acupuncture group still experienced improvement in symptoms (a significant improvement in comparison to the beginning of therapy), the symptoms of the loratadine group started to increase again after the end of treatment. Nevertheless, this difference between both groups was not significant.
Modern medicine requires an evidence-based, double-blind, and placebo-controlled study design in order to prove effectiveness. This is, however, hardly applicable for acupuncture studies. Especially blinding and placebo control present an unsolved problem. Theoretically, a blinding would be possible for laser acupuncture but a comparability of the effectiveness of needle acupuncture with laser acupuncture has not yet been proven. A placebo treatment with acupuncture needles founders on the circumstance that the so-called sham acupuncture, where acupuncture needles are inserted in the acupuncture points, can still have a physiological impact or an effect on the immune system. As the skin is related to internal organs and body systems by the principle of segmental innervations , it is not possible to exclude an impact of the skin irritation on the examined effect.
In our study, we tried to prove the effectiveness of acupuncture in PER through changes in the interleukin level in the serum. However, parameters depending on interleukin can be strongly influenced by factors such as autoimmune diseases, inflammations, or even the weather. It might be for this reason that no significant changes in the interleukin level in the serum could be found. Furthermore, a larger number of participants are necessary to prove significance of the treatment effects. The small number of patients allows in many cases only a statistical tendency to increase.
Despite these limitations, the results at hand make it possible to conclude that acupuncture itself and the acupuncture points used are effective in the treatment of PER. Acupuncture, therefore, presents a suitable alternative for patients with drug intolerance or pregnancy. Further studies with a larger patient collective are necessary to confirm these positive results of the mode of action of acupuncture and to examine the effectiveness of further TCM acupoints.
Acupuncture is an effective, well-tolerated form of therapy in the treatment of patients suffering from dust mite allergy with its effect being comparable to loratadine.
Although the theory that the mechanism of action of acupuncture is based on immunomodulation could not be proven significantly, it was possible to show a tendential increase of the IL-10 level in the serum under acupuncture. For a definite assessment of this issue, further studies with larger numbers of patients are necessary.
Acupuncture can function as an effective therapeutic alternative for patients having a contraindication to specific immunotherapy or to a medicinal symptomatic therapy.
|PER:||Persistent allergic rhinitis|
|TCM:||Traditional Chinese medicine|
The tested subjects were first informed about the studies and their written consents were obtained. The Institutional Review Board considered investigations as safe and in agreement with the principles of the Declaration of Helsinki.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
Bettina Hauswald was the principal investigator of the study and contributed to the protocol design together with Christina Dill, Thomas Zahnert, and Yury M. Yarin. Bettina Hauswald and Christina Dill carried out the acupuncture treatment. Yury M. Yarin and Jürgen Boxberger critically revised the paper. Eberhard Kuhlisch performed the statistical analysis under the guidance of Yury M. Yarin. All authors read and approved the final paper.
- S. M. Choi, J.-E. Park, S.-S. Li et al., “A multicenter, randomized, controlled trial testing the effects of acupuncture on allergic rhinitis,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 68, no. 3, pp. 365–374, 2013.
- R. Mösges and L. Klimek, “Today's allergic rhinitis patients are different: new factors that may play a role,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 62, no. 9, pp. 969–975, 2007.
- V. Bauchau and S. R. Durham, “Prevalence and rate of diagnosis of allergic rhinitis in Europe,” European Respiratory Journal, vol. 24, no. 5, pp. 758–764, 2004.
- J. Bousquet, P. Van Cauwenberge, and N. Khaltaev, “Allergic rhinitis and its impact on asthma,” Journal of Allergy and Clinical Immunology, vol. 108, no. 5, pp. S147–S334, 2001.
- P. Van Cauwenberge, C. Bachert, G. Passalacqua et al., “Consensus statement on the treatment of allergic rhinitis,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 55, no. 2, pp. 116–134, 2000.
- H. P. Zenner, Allergologie in Der Hals-Nasen-Ohren-Heilkunde, Springer, Berlin, Germany, 1993.
- WHO, Acupuncture—Review and Analysis of Reports on Controlled Clinical Trials, WHO, Geneva, Switzerland, 2002.
- C. C. Xue, R. English, J. J. Zhang, C. Da Costa, and C. G. Li, “Effect of acupuncture in the treatment of seasonal allergic rhinitis: a randomized controlled clinical trial,” American Journal of Chinese Medicine, vol. 30, no. 1, pp. 1–11, 2002.
- P. A. Christensen, L. C. Laursen, E. Taudorf, S. C. Sørensen, and B. Weeke, “Acupuncture and bronchial asthma,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 39, no. 5, pp. 379–385, 1984.
- S. Joos, C. Schott, H. Zou, V. Daniel, and E. Martin, “Immunomodulatory effects of acupuncture in the treatment of allergic asthma: a randomized controlled study,” Journal of Alternative and Complementary Medicine, vol. 6, no. 6, pp. 519–525, 2000.
- T. Schäfer, A. Riehle, H.-E. Wichmann, and J. Ring, “Alternative medicine in allergies—prevalence, patterns of use, and costs,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 57, no. 8, pp. 694–700, 2002.
- B. Brinkhaus, M. Ortiz, C. M. Witt et al., “Acupuncture in patients with seasonal allergic rhinitis a randomized trial,” Annals of Internal Medicine, vol. 158, no. 4, pp. 225–234, 2013.
- O. Mastalier, “Möglichkeiten der Akupunktur zur Stimulation des Immunsystems,” Aga Khan University, vol. 21, pp. 19–28, 1993.
- W. Stör, “Immunmodulierende wirkung der akupunktur,” Aga Khan University, vol. 22, no. 3, pp. 188–193, 1994.
- T. Lundeberg, S. V. Eriksson, and E. Theodorsson, “Neuroimmunomodulatory effects of acupuncture in mice,” Neuroscience Letters, vol. 128, no. 2, pp. 161–164, 1991.
- F. Annunziato and S. Romagnani, “Heterogeneity of human effector CD4+ T cells,” Arthritis Research and Therapy, vol. 11, no. 6, article 257, 2009.
- J. A. Woodfolk, “Cytokines as a therapeutic target for allergic diseases: a complex picture,” Current Pharmaceutical Design, vol. 12, no. 19, pp. 2349–2363, 2006.
- J. A. Woodfolk, “T-cell responses to allergens,” Journal of Allergy and Clinical Immunology, vol. 119, no. 2, pp. 280–294, 2007.
- A. Cutler and F. Brombacher, “Cytokine therapy,” Annals of the New York Academy of Sciences, vol. 1056, pp. 16–29, 2005.
- J. A. Woodfolk, “Selective roles and dysregulation of interleukin-10 in allergic disease,” Current Allergy and Asthma Reports, vol. 6, no. 1, pp. 40–46, 2006.
- E. R. Carneiro, R. A. N. Xavier, M. A. P. D. Castro, C. M. O. D. Nascimento, and V. L. F. Silveira, “Electroacupuncture promotes a decrease in inflammatory response associated with Th1/Th2 cytokines, nitric oxide and leukotriene B4 modulation in experimental asthma,” Cytokine, vol. 50, no. 3, pp. 335–340, 2010.
- H.-J. Jeong, B.-S. Kim, J. G. Oh, K.-S. Kim, and H.-M. Kim, “Regulatory effect of cytokine production in asthma patients by SOOJI CHIM,” Immunopharmacology and Immunotoxicology, vol. 24, no. 2, pp. 265–274, 2002.
- B. Hauswald, C. H. Schmidt, J. Knothe, K. B. Hüttenbrink, and T. H. Zahnert, “Effects of acupuncture in treatment of perennial allergic rhinitis in comparison to antihistaminic medication,” Deutsche Zeitschrift für Akupunktur, vol. 52, no. 3, p. 31, 2009.
- F. B. Petti, A. Liguori, and F. Ippoliti, “Study on cytokines IL-2, IL-6, IL-10 in patients of chronic allergic rhinitis treated with acupuncture,” Journal of Traditional Chinese Medicine, vol. 22, no. 2, pp. 104–111, 2002.
- Y. Q. Rao and N. Y. Han, “Therapeutic effect of acupuncture on allergic rhinitis and its effects on immunologic function,” Chinese Acupuncture & Moxibustion, vol. 26, no. 8, pp. 557–560, 2006.
- L. Klimek, J. Saloga, W. Mann, and J. Knop, Allergische Rhinitis—Einführung in Diagnostik Und Therapie, Schattauer, Stuttgart, Germany, 1998.
- V. L. Lund, D. Aaronson, J. Bousquet et al., “International consensus report on the diagnosis and management of rhinitis,” Allergy: European Journal of Allergy and Clinical Immunology, Supplement, vol. 49, no. 19, pp. 1–34, 1994.
- B. Royer, S. Varadaradjalou, P. Saas, J. J. Guillosson, J. P. Kantelip, and M. Arock, “Inhibition of IgE-induced activation of human mast cells by IL-10,” Clinical and Experimental Allergy, vol. 31, no. 5, pp. 694–704, 2001.
- B. Muller, E. J. J. De Groot, I. J. M. Kortekaas, W. J. Fokkens, and C. M. Van Drunen, “Nasal endothelial interleukin-10 expression is negatively correlated with nasal symptoms after allergen provocation,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 64, no. 5, pp. 738–745, 2009.
- B. Hauswald and H. Langer, “Akupunktur und Laserpunktur bei Rhinopathia pollinosa—ergebnisse einer klinisch kontrollierten Studie,” Akupunktur-Theorie Und Praxis, vol. 17, pp. 14–21, 1989.
- H. Langer and B. Hauswald, “Langzeitstudie über die Therapie der Rhinitis pollinosa mittels Akupunktur beziehungsweise Laserakupunktur,” Erfahrungsheilkunde, vol. 4, pp. 262–267, 1992.
- H. Head, Die Sensibilitätsstörungen Der Haut Bei Viszeralerkrankungen, Verlag Hirschwald, Berlin, Germany, 1898.